enalapril + carvedilol

Enalapril + carvedilol is a combination of two antihypertensive agents used together, though not available as a fixed-dose commercial product. Enalapril is an angiotensin-converting enzyme (ACE) inhibitor that lowers blood pressure by inhibiting the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced aldosterone secretion. Carvedilol is a non-selective beta-adrenergic antagonist with additional alpha-1 blocking activity, resulting in decreased heart rate, myocardial contractility, and peripheral vascular resistance. The combination has been studied for its potential to prevent left ventricular systolic dysfunction (LVSD) in patients undergoing intensive chemotherapy for hematological malignancies and may be used off-label in other settings such as heart failure or hypertension where dual neurohormonal blockade is desired[3][6]. Each drug targets different pathways involved in cardiovascular regulation.